This is an old revision of this page, as edited by Beetstra (talk | contribs) at 13:44, 5 December 2011 (Saving copy of the {{drugbox}} taken from revid 458434583 of page Ponezumab for the Chem/Drugbox validation project (updated: 'CAS_number').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 13:44, 5 December 2011 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 458434583 of page Ponezumab for the Chem/Drugbox validation project (updated: 'CAS_number').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This page contains a copy of the infobox ({{drugbox}}) taken from revid 458434583 of page Ponezumab with values updated to verified values. |
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized (from mouse) |
| Target | beta-amyloid |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C6552H10158N1730O2090S52 |
| Molar mass | 148.3 kDa g·mol |
| (what is this?) (verify) | |
